ImmunoVision

ImmunoVision

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $18.5M

Overview

ImmunoVision is a long-established service and product provider in the immunoassay space, operating from San Diego. Its core business revolves around contract development and manufacturing services (CDMO) for immunoassays, including ELISA and CLIA kits, catering primarily to research, biotech, and pharmaceutical clients. The company leverages decades of experience in immunochemistry to offer custom solutions in plate coating, purification, and labeling. It functions as a key service arm within the broader Calbiotech family, supporting research across autoimmune disorders, infectious diseases, and oncology.

Autoimmune DisordersInfectious DiseasesOncology

Technology Platform

Expertise in classical immunochemistry and immunoassay development services, including custom microtiter plate coating, protein/antibody purification and labeling, and assay optimization for ELISA/CLIA formats.

Funding History

2
Total raised:$18.5M
Series A$15M
Seed$3.5M

Opportunities

Sustained growth in biologics and diagnostic R&D drives demand for reliable immunoassay development services.
Integration with Calbiotech provides cross-selling opportunities and allows offering end-to-end solutions from reagent supply to finished assay manufacturing.
The trend toward outsourcing in pharma and biotech benefits established CDMOs.

Risk Factors

Faces intense competition from large life science tools companies and other specialized CDMOs, with services potentially seen as a commodity.
Lack of strong proprietary technology creates lower barriers to entry.
Business is dependent on the strategy and health of its parent organization, Calbiotech.

Competitive Landscape

Operates in a crowded market competing with giant diversified players (e.g., Thermo Fisher, Merck) and numerous specialized reagent/assay developers and CROs. Its differentiation is based on deep expertise in autoimmune reagents, custom service flexibility, and its affiliation with Calbiotech's broader manufacturing capabilities.